Global Cancer Hormone Therapy Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 309938
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Cancer Hormone Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Cancer Hormone Therapy Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Cancer Hormone Therapy Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tamoxifen segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Cancer Hormone Therapy Drugs include Roche, Amgen, Pfizer, Teva, and Takeda, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Cancer Hormone Therapy Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Tamoxifen

Aromatase Inhibitors

Antiandrogens

Androgen Synthesis Inhibitors

Other

Market segment by Application, can be divided into

Breast Cancer

Prostate Cancer

Market segment by players, this report covers

Roche

Amgen

Pfizer

Teva

Takeda

Samyang Biopharmaceuticals

Tolmar

AstraZeneca

Novartis

Aspen

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Cancer Hormone Therapy Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Cancer Hormone Therapy Drugs, with revenue, gross margin and global market share of Cancer Hormone Therapy Drugs from 2019 to 2022.

Chapter 3, the Cancer Hormone Therapy Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Hormone Therapy Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Cancer Hormone Therapy Drugs research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Cancer Hormone Therapy Drugs

1.2 Classification of Cancer Hormone Therapy Drugs by Type

1.2.1 Overview: Global Cancer Hormone Therapy Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Type in 2021

1.2.3 Tamoxifen

1.2.4 Aromatase Inhibitors

1.2.5 Antiandrogens

1.2.6 Androgen Synthesis Inhibitors

1.2.7 Other

1.3 Global Cancer Hormone Therapy Drugs Market by Application

1.3.1 Overview: Global Cancer Hormone Therapy Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Breast Cancer

1.3.3 Prostate Cancer

1.4 Global Cancer Hormone Therapy Drugs Market Size & Forecast

1.5 Global Cancer Hormone Therapy Drugs Market Size and Forecast by Region

1.5.1 Global Cancer Hormone Therapy Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Cancer Hormone Therapy Drugs Market Size by Region, (2017-2022)

1.5.3 North America Cancer Hormone Therapy Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Cancer Hormone Therapy Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Cancer Hormone Therapy Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Cancer Hormone Therapy Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Cancer Hormone Therapy Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cancer Hormone Therapy Drugs Market Drivers

1.6.2 Cancer Hormone Therapy Drugs Market Restraints

1.6.3 Cancer Hormone Therapy Drugs Trends Analysis

2 Company Profiles

2.1 Roche

2.1.1 Roche Details

2.1.2 Roche Major Business

2.1.3 Roche Cancer Hormone Therapy Drugs Product and Solutions

2.1.4 Roche Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Roche Recent Developments and Future Plans

2.2 Amgen

2.2.1 Amgen Details

2.2.2 Amgen Major Business

2.2.3 Amgen Cancer Hormone Therapy Drugs Product and Solutions

2.2.4 Amgen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Amgen Recent Developments and Future Plans

2.3 Pfizer

2.3.1 Pfizer Details

2.3.2 Pfizer Major Business

2.3.3 Pfizer Cancer Hormone Therapy Drugs Product and Solutions

2.3.4 Pfizer Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Pfizer Recent Developments and Future Plans

2.4 Teva

2.4.1 Teva Details

2.4.2 Teva Major Business

2.4.3 Teva Cancer Hormone Therapy Drugs Product and Solutions

2.4.4 Teva Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Teva Recent Developments and Future Plans

2.5 Takeda

2.5.1 Takeda Details

2.5.2 Takeda Major Business

2.5.3 Takeda Cancer Hormone Therapy Drugs Product and Solutions

2.5.4 Takeda Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Takeda Recent Developments and Future Plans

2.6 Samyang Biopharmaceuticals

2.6.1 Samyang Biopharmaceuticals Details

2.6.2 Samyang Biopharmaceuticals Major Business

2.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product and Solutions

2.6.4 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Samyang Biopharmaceuticals Recent Developments and Future Plans

2.7 Tolmar

2.7.1 Tolmar Details

2.7.2 Tolmar Major Business

2.7.3 Tolmar Cancer Hormone Therapy Drugs Product and Solutions

2.7.4 Tolmar Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Tolmar Recent Developments and Future Plans

2.8 AstraZeneca

2.8.1 AstraZeneca Details

2.8.2 AstraZeneca Major Business

2.8.3 AstraZeneca Cancer Hormone Therapy Drugs Product and Solutions

2.8.4 AstraZeneca Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 AstraZeneca Recent Developments and Future Plans

2.9 Novartis

2.9.1 Novartis Details

2.9.2 Novartis Major Business

2.9.3 Novartis Cancer Hormone Therapy Drugs Product and Solutions

2.9.4 Novartis Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Novartis Recent Developments and Future Plans

2.10 Aspen

2.10.1 Aspen Details

2.10.2 Aspen Major Business

2.10.3 Aspen Cancer Hormone Therapy Drugs Product and Solutions

2.10.4 Aspen Cancer Hormone Therapy Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Aspen Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cancer Hormone Therapy Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Cancer Hormone Therapy Drugs Players Market Share in 2021

3.2.2 Top 10 Cancer Hormone Therapy Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Cancer Hormone Therapy Drugs Players Head Office, Products and Services Provided

3.4 Cancer Hormone Therapy Drugs Mergers & Acquisitions

3.5 Cancer Hormone Therapy Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cancer Hormone Therapy Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Cancer Hormone Therapy Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Cancer Hormone Therapy Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Cancer Hormone Therapy Drugs Revenue by Type (2017-2028)

6.2 North America Cancer Hormone Therapy Drugs Revenue by Application (2017-2028)

6.3 North America Cancer Hormone Therapy Drugs Market Size by Country

6.3.1 North America Cancer Hormone Therapy Drugs Revenue by Country (2017-2028)

6.3.2 United States Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Cancer Hormone Therapy Drugs Revenue by Type (2017-2028)

7.2 Europe Cancer Hormone Therapy Drugs Revenue by Application (2017-2028)

7.3 Europe Cancer Hormone Therapy Drugs Market Size by Country

7.3.1 Europe Cancer Hormone Therapy Drugs Revenue by Country (2017-2028)

7.3.2 Germany Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

7.3.3 France Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region

8.3.1 Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Region (2017-2028)

8.3.2 China Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

8.3.5 India Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Cancer Hormone Therapy Drugs Revenue by Type (2017-2028)

9.2 South America Cancer Hormone Therapy Drugs Revenue by Application (2017-2028)

9.3 South America Cancer Hormone Therapy Drugs Market Size by Country

9.3.1 South America Cancer Hormone Therapy Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country

10.3.1 Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Cancer Hormone Therapy Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cancer Hormone Therapy Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Cancer Hormone Therapy Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Cancer Hormone Therapy Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Cancer Hormone Therapy Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Cancer Hormone Therapy Drugs Revenue Market Share by Region (2023-2028)

Table 6. Roche Corporate Information, Head Office, and Major Competitors

Table 7. Roche Major Business

Table 8. Roche Cancer Hormone Therapy Drugs Product and Solutions

Table 9. Roche Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Amgen Corporate Information, Head Office, and Major Competitors

Table 11. Amgen Major Business

Table 12. Amgen Cancer Hormone Therapy Drugs Product and Solutions

Table 13. Amgen Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Pfizer Corporate Information, Head Office, and Major Competitors

Table 15. Pfizer Major Business

Table 16. Pfizer Cancer Hormone Therapy Drugs Product and Solutions

Table 17. Pfizer Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Teva Corporate Information, Head Office, and Major Competitors

Table 19. Teva Major Business

Table 20. Teva Cancer Hormone Therapy Drugs Product and Solutions

Table 21. Teva Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Takeda Corporate Information, Head Office, and Major Competitors

Table 23. Takeda Major Business

Table 24. Takeda Cancer Hormone Therapy Drugs Product and Solutions

Table 25. Takeda Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Samyang Biopharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 27. Samyang Biopharmaceuticals Major Business

Table 28. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product and Solutions

Table 29. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Tolmar Corporate Information, Head Office, and Major Competitors

Table 31. Tolmar Major Business

Table 32. Tolmar Cancer Hormone Therapy Drugs Product and Solutions

Table 33. Tolmar Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 35. AstraZeneca Major Business

Table 36. AstraZeneca Cancer Hormone Therapy Drugs Product and Solutions

Table 37. AstraZeneca Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Novartis Corporate Information, Head Office, and Major Competitors

Table 39. Novartis Major Business

Table 40. Novartis Cancer Hormone Therapy Drugs Product and Solutions

Table 41. Novartis Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Aspen Corporate Information, Head Office, and Major Competitors

Table 43. Aspen Major Business

Table 44. Aspen Cancer Hormone Therapy Drugs Product and Solutions

Table 45. Aspen Cancer Hormone Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Cancer Hormone Therapy Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Cancer Hormone Therapy Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Cancer Hormone Therapy Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Cancer Hormone Therapy Drugs Players Head Office, Products and Services Provided

Table 50. Cancer Hormone Therapy Drugs Mergers & Acquisitions in the Past Five Years

Table 51. Cancer Hormone Therapy Drugs New Entrants and Expansion Plans

Table 52. Global Cancer Hormone Therapy Drugs Revenue (USD Million) by Type (2017-2022)

Table 53. Global Cancer Hormone Therapy Drugs Revenue Share by Type (2017-2022)

Table 54. Global Cancer Hormone Therapy Drugs Revenue Forecast by Type (2023-2028)

Table 55. Global Cancer Hormone Therapy Drugs Revenue by Application (2017-2022)

Table 56. Global Cancer Hormone Therapy Drugs Revenue Forecast by Application (2023-2028)

Table 57. North America Cancer Hormone Therapy Drugs Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Cancer Hormone Therapy Drugs Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Cancer Hormone Therapy Drugs Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Cancer Hormone Therapy Drugs Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Cancer Hormone Therapy Drugs Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Cancer Hormone Therapy Drugs Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Cancer Hormone Therapy Drugs Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Cancer Hormone Therapy Drugs Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Cancer Hormone Therapy Drugs Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Cancer Hormone Therapy Drugs Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Cancer Hormone Therapy Drugs Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Cancer Hormone Therapy Drugs Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Cancer Hormone Therapy Drugs Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Cancer Hormone Therapy Drugs Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Cancer Hormone Therapy Drugs Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Cancer Hormone Therapy Drugs Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Cancer Hormone Therapy Drugs Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Cancer Hormone Therapy Drugs Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Cancer Hormone Therapy Drugs Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Cancer Hormone Therapy Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Cancer Hormone Therapy Drugs Picture

Figure 2. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type in 2021

Figure 3. Tamoxifen

Figure 4. Aromatase Inhibitors

Figure 5. Antiandrogens

Figure 6. Androgen Synthesis Inhibitors

Figure 7. Other

Figure 8. Cancer Hormone Therapy Drugs Revenue Market Share by Application in 2021

Figure 9. Breast Cancer Picture

Figure 10. Prostate Cancer Picture

Figure 11. Global Cancer Hormone Therapy Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Cancer Hormone Therapy Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Cancer Hormone Therapy Drugs Revenue Market Share by Region (2017-2028)

Figure 14. Global Cancer Hormone Therapy Drugs Revenue Market Share by Region in 2021

Figure 15. North America Cancer Hormone Therapy Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Cancer Hormone Therapy Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Cancer Hormone Therapy Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Cancer Hormone Therapy Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Cancer Hormone Therapy Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Cancer Hormone Therapy Drugs Market Drivers

Figure 21. Cancer Hormone Therapy Drugs Market Restraints

Figure 22. Cancer Hormone Therapy Drugs Market Trends

Figure 23. Roche Recent Developments and Future Plans

Figure 24. Amgen Recent Developments and Future Plans

Figure 25. Pfizer Recent Developments and Future Plans

Figure 26. Teva Recent Developments and Future Plans

Figure 27. Takeda Recent Developments and Future Plans

Figure 28. Samyang Biopharmaceuticals Recent Developments and Future Plans

Figure 29. Tolmar Recent Developments and Future Plans

Figure 30. AstraZeneca Recent Developments and Future Plans

Figure 31. Novartis Recent Developments and Future Plans

Figure 32. Aspen Recent Developments and Future Plans

Figure 33. Global Cancer Hormone Therapy Drugs Revenue Share by Players in 2021

Figure 34. Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Cancer Hormone Therapy Drugs Revenue Market Share in 2021

Figure 36. Global Top 10 Players Cancer Hormone Therapy Drugs Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Cancer Hormone Therapy Drugs Revenue Share by Type in 2021

Figure 39. Global Cancer Hormone Therapy Drugs Market Share Forecast by Type (2023-2028)

Figure 40. Global Cancer Hormone Therapy Drugs Revenue Share by Application in 2021

Figure 41. Global Cancer Hormone Therapy Drugs Market Share Forecast by Application (2023-2028)

Figure 42. North America Cancer Hormone Therapy Drugs Sales Market Share by Type (2017-2028)

Figure 43. North America Cancer Hormone Therapy Drugs Sales Market Share by Application (2017-2028)

Figure 44. North America Cancer Hormone Therapy Drugs Revenue Market Share by Country (2017-2028)

Figure 45. United States Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Cancer Hormone Therapy Drugs Sales Market Share by Type (2017-2028)

Figure 49. Europe Cancer Hormone Therapy Drugs Sales Market Share by Application (2017-2028)

Figure 50. Europe Cancer Hormone Therapy Drugs Revenue Market Share by Country (2017-2028)

Figure 51. Germany Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Cancer Hormone Therapy Drugs Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Cancer Hormone Therapy Drugs Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Cancer Hormone Therapy Drugs Revenue Market Share by Region (2017-2028)

Figure 59. China Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Cancer Hormone Therapy Drugs Sales Market Share by Type (2017-2028)

Figure 66. South America Cancer Hormone Therapy Drugs Sales Market Share by Application (2017-2028)

Figure 67. South America Cancer Hormone Therapy Drugs Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Cancer Hormone Therapy Drugs Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Cancer Hormone Therapy Drugs Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Cancer Hormone Therapy Drugs Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Cancer Hormone Therapy Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz